索引超出了数组界限。
[1] Cruz-Jentoft AJ, Sayer AA. Sarcopenia[J]. Lancet, 2019, 393(10191):
2636-2646.
[2] Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised
European consensus on definition and diagnosis[J]. Age Ageing,
2019, 48(1): 16-31.
[3] Barazzoni R, Bischoff SC, Boirie Y, et al. Sarcopenic obesity: time to
meet the challenge[J]. Clin Nutr, 2018, 37(6 Pt A): 1787-1793.
[4] 中华医学会骨质疏松和骨矿盐疾病分会. 肌少症共识[J]. 中华骨
质疏松和骨矿盐疾病杂志, 2016, 9(03): 215-227.
[5] Mayhew AJ, Amog K, Phillips S, et al. The prevalence of sarcopenia
in community-dwelling older adults, an exploration of differences
between studies and within definitions: a systematic review and metaanalyses[
J]. Age Ageing, 2019, 48(1): 48-56.
[6] Kitamura A, Seino S, Abe T, et al. Sarcopenia: prevalence, associated
factors, and the risk of mortality and disability in Japanese older
adults[J]. J Cachexia Sarcopenia Muscle, 2021, 12(1): 30-38.
[7] Pang BWJ, Wee SL, Lau LK, et al. Prevalence and associated factors
of sarcopenia in Singaporean adults-The Yishun Study[J]. J Am Med
Dir Assoc, 2021, 22(4): 885.e1-885.e10.
[8] Chen Z, Li WY, Ho M, et al. The Prevalence of sarcopenia in Chinese
older adults: meta-analysis and meta-regression[J]. Nutrients, 2021,
13(5): 1441.
[9] Wiedmer P, Jung T, Castro JP, et al. Sarcopenia - Molecular
mechanisms and open questions[J]. Ageing Res Rev, 2021, 65:
101200.
[10] Goljanek-Whysall K, Iwanejko LA, Vasilaki A, et al. Ageing in
relation to skeletal muscle dysfunction: redox homoeostasis to
regulation of gene expression[J]. Mamm Genome, 2016, 27(7-8):
341-357.
[11] Gensous N, Bacalini MG, Franceschi C, et al. Age-related DNA
methylation changes: potential impact on skeletal muscle aging in
humans[J]. Front Physiol, 2019, 10: 996.
[12] Li L, Xiong WC, Mei L. Neuromuscular junction formation, aging,
and disorders[J]. Annu Rev Physiol, 2018, 80: 159-188.
[13] Wohlwend M, Laurila PP, Williams K, et al. The exercise-induced
long noncoding RNA CYTOR promotes fast-twitch myogenesis in
aging[J]. Sci Transl Med, 2021, 13(623): eabc7367.
[14] Bian A, Ma Y, Zhou X, et al. Association between sarcopenia and
levels of growth hormone and insulin-like growth factor-1 in the
elderly[J]. BMC Musculoskelet Disord, 2020, 21(1): 214.
[15] Halmos T, Suba I. The physiological role of growth hormone and
insulin-like growth factors[J]. Orv Hetil, 2019, 160(45): 1774-1783.
[16] Morley JE. Hormones and sarcopenia[J]. Curr Pharm Des, 2017,
23(30): 4484-4492.
[17] Argilés JM. The 2015 ESPEN Sir David Cuthbertson lecture:
Inflammation as the driving force of muscle wasting in cancer[J].
Clin Nutr, 2017, 36(3): 798-803.
[18] Argilés JM, Busquets S, Toledo M, et al. The role of cytokines in
cancer cachexia[J]. Curr Opin Support Palliat Care, 2009, 3(4): 263-
268.
[19] 于宝海, 吴文娟. 2018 欧洲肌少症共识解读[J]. 河北医科大学学
报, 2019, 40(4): 373-379.
[20] 姜珊, 康琳, 刘晓红. 2019 亚洲肌少症诊断及治疗共识解读[J].
中华老年医学杂志, 2020, 39(4): 373-376.
[21] Mazocco L, Chagas P, Barbosa-Silva TG, et al. Accuracy of SARC-F
and SARC-CalF for sarcopenia screening in older women from
southern Brazil[J]. Nutrition, 2020, 79-80: 110955.
[22] Fu X, Tian Z, Thapa S, et al. Comparing SARC-F with SARC-CalF
for screening sarcopenia in advanced cancer patients[J]. Clin Nutr,
2020, 39(11): 3337-3345.
[23] Auyeung TW, Arai H, Chen LK, et al. Letter to the editor: Normative
data of handgrip strength in 26344 older adults: a pooled dataset from
eight cohorts in Asia[J]. J Nutr Health Aging, 2020, 24(1): 125-126.
[24] Albano D, Messina C, Vitale J, et al. Imaging of sarcopenia: old
evidence and new insights[J]. Eur Radiol, 2020, 30(4): 2199-2208.
[25] Bosy-Westphal A, Schautz B, Later W, et al. What makes a BIA
equation unique? Validity of eight-electrode multifrequency BIA to
estimate body composition in a healthy adult population[J]. Eur J
Clin Nutr, 2013, 67(Suppl 1): S14-S21.
[26] Cheng KYK, Chow SKH, Hung VWY, et al. Diagnosis of sarcopenia
by evaluating skeletal muscle mass by adjusted bioimpedance
analysis validated with dual-energy X-ray absorptiometry[J]. J
Cachexia Sarcopenia Muscle, 2021, 12(6): 2163-2173.
[27] Tagliafico AS, Bignotti B, Torri L, et al. Sarcopenia: how to measure,
when and why[J]. Radiol Med, 2022, 127(3): 228-237.
[28] Mitsiopoulos N, Baumgartner RN, Heymsfield SB, et al. Cadaver
validation of skeletal muscle measurement by magnetic resonance
imaging and computerized tomography[J]. J Appl Physiol (1985),
1998, 85(1): 115-122.
[29] Beretta-Piccoli M, Cescon C, Barbero M, et al. Reliability of surface
electromyography in estimating muscle fiber conduction velocity: a
systematic review[J]. J Electromyogr Kinesiol, 2019, 48: 53-68.
[30] Chowdhury RH, Reaz MBI, Ali MABM, et al. Surface electromyography
signal processing and classification techniques[J]. Sensors (Basel),
2013, 13(9): 12431-12466.
[31] Narici M, McPhee J, Conte M, et al. Age-related alterations in muscle
architecture are a signature of sarcopenia: the ultrasound sarcopenia
index[J]. J Cachexia Sarcopenia Muscle, 2021, 12(4): 973-982.
[32] Schaap LA. D3-Creatine dilution to assess muscle mass[J]. J Gerontol
A Biol Sci Med Sci, 2019, 74(6): 842-843.
[33] Zhu K, Wactawski-Wende J, Ochs-Balcom HM, et al. The association
of muscle mass measured by D3-Creatine dilution method with
dual-energy X-Ray absorptiometry and physical function in
postmenopausal women[J]. J Gerontol A Biol Sci Med Sci, 2021,
76(9): 1591-1599.
[34] Kakehi S, Wakabayashi H, Inuma H, et al. Rehabilitation nutrition
and exercise therapy for sarcopenia[J]. World J Mens Health, 2022,
40(1): 1-10.
[35] 邓玉洁, 李维辛. 运动改善肌少症的免疫机制研究进展[J]. 基础
医学与临床, 2021, 41(6): 909-913.
[36] 周晓宁, 许金海, 王国栋, 等. 肌少症治疗[J]. 中华骨质疏松和骨
矿盐疾病杂志, 2020, 13(3): 272-279.
[37] 杨则宜, 焦颖, 魏冰, 等. 老年肌肉减少症防治中的营养干预[J].
中国食品学报, 2019, 19(9): 1-12.
[38] Rooks D, Roubenoff R. Development of pharmacotherapies for the
treatment of sarcopenia[J]. J Frailty Aging, 2019, 8(3): 120-130.
[39] Hardee JP, Lynch GS. Current pharmacotherapies for sarcopenia[J].
Expert Opin Pharmacother, 2019, 20(13): 1645-1657.
[40] Devrimsel G, Metin Y, Serdaroglu Beyazal M. Short-term effects
of neuromuscular electrical stimulation and ultrasound therapies on
muscle architecture and functional capacity in knee osteoarthritis: a
randomized study[J]. Clin Rehabil, 2019, 33(3): 418-427.
[41] 陈蓉, 曾庆, 巩泽, 等. 不同模式下血流限制治疗老年性肌肉减少
症的效果与安全因素[J]. 中国组织工程研究, 2021, 25(32): 5215-
5221.